Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REBOXETINE vs RELATLIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REBOXETINE vs RELATLIMAB: Safety Overview

Metric REBOXETINE RELATLIMAB
Total FAERS Reports 185 177
Deaths Reported 19 29
Death Rate 10.3% 16.4%
Hospitalizations 63 145
Average Patient Age 53.6 yrs 64.5 yrs
% Female Patients 62.7% 34.6%